IL222491A - Compounds of benzamide for the treatment of 5-ht4 receptor-related disorders, pharmaceuticals containing them and a method for preparing these compounds - Google Patents
Compounds of benzamide for the treatment of 5-ht4 receptor-related disorders, pharmaceuticals containing them and a method for preparing these compoundsInfo
- Publication number
- IL222491A IL222491A IL222491A IL22249112A IL222491A IL 222491 A IL222491 A IL 222491A IL 222491 A IL222491 A IL 222491A IL 22249112 A IL22249112 A IL 22249112A IL 222491 A IL222491 A IL 222491A
- Authority
- IL
- Israel
- Prior art keywords
- compounds
- receptor
- preparing
- pharmaceutical compositions
- disorders related
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020100038039A KR101180174B1 (ko) | 2010-04-23 | 2010-04-23 | 신규한 벤즈아미드 유도체 |
| PCT/KR2011/002759 WO2011132901A2 (en) | 2010-04-23 | 2011-04-18 | Novel benzamide derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL222491A0 IL222491A0 (en) | 2012-12-31 |
| IL222491A true IL222491A (en) | 2016-07-31 |
Family
ID=44834616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL222491A IL222491A (en) | 2010-04-23 | 2012-10-16 | Compounds of benzamide for the treatment of 5-ht4 receptor-related disorders, pharmaceuticals containing them and a method for preparing these compounds |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9221790B2 (ko) |
| EP (1) | EP2560955B1 (ko) |
| JP (1) | JP5564147B2 (ko) |
| KR (1) | KR101180174B1 (ko) |
| CN (1) | CN102844301B (ko) |
| AU (1) | AU2011243393B2 (ko) |
| BR (1) | BR112012026509B1 (ko) |
| CA (1) | CA2794176C (ko) |
| ES (1) | ES2594708T3 (ko) |
| HK (1) | HK1176061A1 (ko) |
| IL (1) | IL222491A (ko) |
| MX (1) | MX2012011721A (ko) |
| MY (1) | MY162554A (ko) |
| NZ (1) | NZ602612A (ko) |
| RU (1) | RU2536688C2 (ko) |
| SG (1) | SG184350A1 (ko) |
| UA (1) | UA107702C2 (ko) |
| WO (1) | WO2011132901A2 (ko) |
| ZA (1) | ZA201207903B (ko) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101341693B1 (ko) | 2011-03-16 | 2013-12-16 | 동아에스티 주식회사 | 생약추출물을 함유하는 퇴행성 신경질환의 치료 및 예방을 위한 조성물 |
| KR101341692B1 (ko) | 2011-03-16 | 2013-12-20 | 동아에스티 주식회사 | 복합생약추출물을 함유하는 당뇨병성 말초 신경병증의 치료 및 예방을 위한 조성물 |
| KR101457789B1 (ko) | 2013-02-13 | 2014-11-03 | 동아제약 주식회사 | 상처 치료용 필름형성 약제학적 조성물 및 그의 제조방법 |
| ES2897946T3 (es) * | 2013-07-25 | 2022-03-03 | Dong A St Co Ltd | Método para preparar un derivado de benzamida, intermedio novedoso utilizado en la preparación de la benzamida y método para preparar un intermedio novedoso |
| CN104230889A (zh) * | 2014-08-29 | 2014-12-24 | 南京大学 | 环丙沙星衍生物及其制备方法与用途 |
| KR102394635B1 (ko) * | 2015-03-31 | 2022-05-09 | (주)아모레퍼시픽 | 5-아다만탄-1-일-n-(2,4-다이하이드록시벤질)-2,4-다이메톡시벤즈아마이드를 함유하는 항산화 또는 항노화 조성물 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1507462A (en) | 1974-03-21 | 1978-04-12 | Gallardo Antonio Sa | N-heterocyclic substituted benzamides methods for their preparation and compositions containing them |
| US5057525A (en) | 1981-10-01 | 1991-10-15 | Janssen Pharmaceutica N.V. | Novel N-(3-hydroxy-4-piperidinyl) benzamide derivatives |
| US5137896A (en) | 1981-10-01 | 1992-08-11 | Janssen Pharmaceutica N.V. | N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
| US4962115A (en) | 1981-10-01 | 1990-10-09 | Janssen Pharmaceutica N.V. | Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
| KR970702247A (ko) | 1994-03-30 | 1997-05-13 | 고야 마사시 | 벤조산 화합물 및 이들의 약제로서의 용도(benzoic acid compound and use thereof as medicine) |
| US5864039A (en) | 1994-03-30 | 1999-01-26 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzoic acid compounds and use thereof as medicaments |
| TW548103B (en) | 1997-07-11 | 2003-08-21 | Janssen Pharmaceutica Nv | Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| BR9915735A (pt) | 1998-11-20 | 2001-09-04 | Hoffmann La Roche | Antagonistas receptores de ccr-3 de piperidina |
| EP1217000A1 (en) * | 2000-12-23 | 2002-06-26 | Aventis Pharma Deutschland GmbH | Inhibitors of factor Xa and factor VIIa |
| FR2861073B1 (fr) * | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique |
| KR100854211B1 (ko) | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
| KR100976063B1 (ko) | 2007-03-16 | 2010-08-17 | 동아제약주식회사 | 신규한 벤즈아미드 유도체 화합물 및 그의 제조방법 |
| AU2008241692B2 (en) | 2007-04-19 | 2011-02-10 | Dong-A Pharm. Co., Ltd. | DPP-IV inhibitor including beta-amino group, preparation method thereof and pharmaceutical composition containing the same for preventing and treating a diabetes or an obesity |
| US8642772B2 (en) | 2008-10-14 | 2014-02-04 | Sk Biopharmaceuticals Co., Ltd. | Piperidine compounds, pharmaceutical composition comprising the same and its use |
| WO2010062959A1 (en) | 2008-11-26 | 2010-06-03 | Aryx Therapeutics, Inc. | 5-ht4 receptor agonists for treating irritable bowel syndrome and colonic hypersensitivity |
| BR112012023139A2 (pt) | 2010-03-24 | 2018-06-26 | Dong A Pharm Co Ltd | composição farmacêutica para a prevenção ou o tratamento de doença do fígado gordo não alcóolico e o método para a prevenção ou tratamento de doença do fígado gordo não alcóolico usando a mesma. |
| US20140155609A9 (en) | 2010-11-24 | 2014-06-05 | Dong-A St Co., Ltd. | Quinoline derivative compound, method for preparing same, and pharmaceutical composition containing same |
| WO2012070700A1 (ko) | 2010-11-24 | 2012-05-31 | 동아제약주식회사 | 퀴놀린 유도체 화합물, 이의 제조방법 및 이를 포함하는 약학 조성물 |
| KR101341692B1 (ko) | 2011-03-16 | 2013-12-20 | 동아에스티 주식회사 | 복합생약추출물을 함유하는 당뇨병성 말초 신경병증의 치료 및 예방을 위한 조성물 |
| KR101341693B1 (ko) | 2011-03-16 | 2013-12-16 | 동아에스티 주식회사 | 생약추출물을 함유하는 퇴행성 신경질환의 치료 및 예방을 위한 조성물 |
-
2010
- 2010-04-23 KR KR1020100038039A patent/KR101180174B1/ko active IP Right Grant
-
2011
- 2011-04-18 US US13/641,867 patent/US9221790B2/en active Active
- 2011-04-18 UA UAA201213255A patent/UA107702C2/ru unknown
- 2011-04-18 JP JP2013506071A patent/JP5564147B2/ja active Active
- 2011-04-18 NZ NZ602612A patent/NZ602612A/en not_active IP Right Cessation
- 2011-04-18 BR BR112012026509-1A patent/BR112012026509B1/pt active IP Right Grant
- 2011-04-18 SG SG2012072450A patent/SG184350A1/en unknown
- 2011-04-18 AU AU2011243393A patent/AU2011243393B2/en active Active
- 2011-04-18 CN CN201180020476.6A patent/CN102844301B/zh active Active
- 2011-04-18 RU RU2012150037/04A patent/RU2536688C2/ru not_active IP Right Cessation
- 2011-04-18 MY MYPI2012004698A patent/MY162554A/en unknown
- 2011-04-18 WO PCT/KR2011/002759 patent/WO2011132901A2/en active Application Filing
- 2011-04-18 CA CA2794176A patent/CA2794176C/en active Active
- 2011-04-18 MX MX2012011721A patent/MX2012011721A/es not_active Application Discontinuation
- 2011-04-18 EP EP11772189.4A patent/EP2560955B1/en active Active
- 2011-04-18 ES ES11772189.4T patent/ES2594708T3/es active Active
-
2012
- 2012-10-16 IL IL222491A patent/IL222491A/en not_active IP Right Cessation
- 2012-10-19 ZA ZA2012/07903A patent/ZA201207903B/en unknown
-
2013
- 2013-03-15 HK HK13103256.8A patent/HK1176061A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013525344A (ja) | 2013-06-20 |
| AU2011243393A1 (en) | 2012-10-18 |
| CA2794176C (en) | 2015-12-15 |
| US9221790B2 (en) | 2015-12-29 |
| EP2560955A2 (en) | 2013-02-27 |
| HK1176061A1 (en) | 2013-07-19 |
| KR20110118446A (ko) | 2011-10-31 |
| MY162554A (en) | 2017-06-15 |
| RU2012150037A (ru) | 2014-05-27 |
| ZA201207903B (en) | 2013-06-26 |
| UA107702C2 (en) | 2015-02-10 |
| CN102844301A (zh) | 2012-12-26 |
| BR112012026509B1 (pt) | 2021-01-19 |
| WO2011132901A3 (en) | 2012-01-26 |
| BR112012026509A2 (pt) | 2017-10-31 |
| RU2536688C2 (ru) | 2014-12-27 |
| EP2560955A4 (en) | 2013-09-11 |
| AU2011243393B2 (en) | 2014-07-17 |
| WO2011132901A2 (en) | 2011-10-27 |
| US20130085160A1 (en) | 2013-04-04 |
| JP5564147B2 (ja) | 2014-07-30 |
| EP2560955B1 (en) | 2016-06-29 |
| CN102844301B (zh) | 2015-04-22 |
| SG184350A1 (en) | 2012-11-29 |
| IL222491A0 (en) | 2012-12-31 |
| ES2594708T3 (es) | 2016-12-22 |
| NZ602612A (en) | 2014-11-28 |
| KR101180174B1 (ko) | 2012-09-05 |
| MX2012011721A (es) | 2012-12-17 |
| CA2794176A1 (en) | 2011-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268984B (en) | Derivatives of oxyntomodulin and a pharmaceutical preparation containing them for the treatment of obesity | |
| IL214572A (en) | Annals of 9 - Alkylaryl - 9h - Furin - 6 - Converted Illamine, a Pharmaceutical Composition Containing Them and These Compounds That Are a Toll-like Colton Antagonist for the Treatment of Disease | |
| PL2568887T3 (pl) | Urządzenie do dostarczania kompozycji leczącej tkanki do zszywanej tkanki | |
| EP2523944A4 (en) | COMPOUNDS AND COMPOSITIONS FOR IMPROVING COGNITION, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT | |
| PT2576669T (pt) | Produtos de carga mineral tratada, seu processo de preparação e utilizações dos mesmos | |
| IL231121B (en) | A pharmaceutical preparation for the treatment of degenerative joint disease | |
| IL222491A (en) | Compounds of benzamide for the treatment of 5-ht4 receptor-related disorders, pharmaceuticals containing them and a method for preparing these compounds | |
| GB201202773D0 (en) | Compositions for treatment of skin disorders | |
| IL223872A (en) | Pyrazoloquinoline derivatives and intermediates, process for preparation, use and pharmaceutical preparations and preparations containing them | |
| IL222841B (en) | Cadherin-11 antagonist for the treatment of leprosy | |
| ZA201202721B (en) | Process for the preparation of sorafenib tosylate | |
| IL207183A (en) | Dihydroindolone compounds, a process for their preparation and their pharmaceutical compositions | |
| EP2697238A4 (en) | SOLID FORMS OF ANTIRETROVIRUS COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITION | |
| IL228019A (en) | Compounds of histamine 3h receptor antagonists, a process for their preparation and uses | |
| HK1197235A1 (zh) | 二氫吡唑、其藥物組合物及其治療生育障礙的用途 | |
| EP2675275A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF OBESITY AND RELATED DISORDERS | |
| EP2687532A4 (en) | NOVEL OCTAHYDROTHENOQUINOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING THE DERIVATIVE, AND USE THEREOF | |
| ZA201309559B (en) | Comptothecin derivative, method for preparing same, pharmaceutical composition and use thereof | |
| IL220709A (en) | Sulfonate Compound Ligand Compounds for Receptor 5-6ht | |
| EP2742946A4 (en) | PROCESS FOR THE PRODUCTION OF PYROSTEGIA VENUSTA DERIVATIVES, PYROSTEGIA VENUSTA DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | |
| AP2012006645A0 (en) | Pharmaceutical compositions comprising paracetamoland process for preparing the same | |
| EP2533780A4 (en) | 5-HT4 RECEPTOR AGONISTS FOR THE TREATMENT OF DEMENTIA | |
| WO2012158493A3 (en) | Compounds that bind to the erythropoietin receptor | |
| HUP1100532A2 (en) | Substituted curcumin derivatives, process for their preparation, and pharmaceutical compositions containing them | |
| SI2497774T1 (sl) | Derivati dihidrooksazolobenzodiazepinona, postopki za njihovo pripravo in farmacevtski sestavki, ki te spojine vsebujejo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| MM9K | Patent not in force due to non-payment of renewal fees |